Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

New compounds were made that are promising for prostate cancer therapy.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

Minoxidil nanocrystals improved hair growth in mice more effectively and safely than regular Minoxidil.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Adding a second method to PROTACs could improve cancer treatment.

Chemicals from the plant Dicerocaryum senecioides were found to safely speed up and increase hair growth in mice.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

New cancer treatments aim to reduce side effects and improve effectiveness.

Understanding how androgens work is key for creating new treatments for prostate issues and hair/skin conditions.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.